Doheny Eye Institute

12/08/2025

🚨 Registration is now open!
We’re excited to invite you to the 4th Annual Doheny–UCLA International Retina Symposium, a full day of learning and connection for general ophthalmologists, retina specialists, fellows, residents, and students.

This year’s keynote speakers include:
✨ Sobha Sivaprasad, MD, FRCOphth (Moorfields Eye Hospital, UK)
✨ Mark W. Johnson, MD (University of Michigan)

Join us for timely updates on AMD treatments, surgical advances, and breakthrough translational research shaping the future of retina care.

📅 Saturday, January 31, 2026
🕣 Breakfast 7:30–8:00 AM | Program 8:00 AM–3:30 PM
📍 Doheny Eye Institute, Pasadena
🎓 Earn up to 7 AMA PRA Category 1 Credits™
🅿️ Complimentary parking
🎓 Complimentary registration for Doheny PAA members, residents, fellows, and medical students

👉 Register today at:

Learn about upcoming events at Doheny Eye Institute.

12/04/2025

The newest issue of InSight has arrived! Inside, you’ll find inspiring stories of discovery and generosity, a spotlight on our newest principal investigator, donor recognition, Glaucoma Symposium highlights, and much more.

Read the full issue now at doheny.org.

12/04/2025

Today, December 3, we recognize the International Day of Persons with Disabilities. Around the world, more than 1.3 billion people live with a significant disability, and vision loss remains a major part of that global challenge. At Doheny Eye Institute, our researchers and clinician-scientists are working to better understand, diagnose, and treat blinding eye diseases so fewer lives are defined by vision loss. Today and every day, we remain committed to protecting sight and preserving independence.

12/02/2025

This Giving Tuesday, your generosity helps fuel sight-saving discoveries at Doheny Eye Institute. Every gift supports the researchers, clinicians, and trainees working to prevent blindness and restore vision for future generations. Join us in making an impact that truly changes lives.

Give today at doheny.org.

11/27/2025

This Thanksgiving, we’re especially grateful for our community of supporters, clinicians, scientists, and friends who make our work possible. Your generosity helps protect the gift of sight for patients and families everywhere. From all of us at Doheny, thank you and happy Thanksgiving.

11/22/2025

Serious vision loss is among the top 10 most common disabilities in U.S. adults and often leads to less independence, a higher risk of falls, and a reduced quality of life. In our continued support of the National Alliance for Eye and Vision Research (NAEVR), we’ve joined the campaign to highlight why vision research must remain a national priority. Vision is priceless—and continued research is essential to preserving it.

11/21/2025

Thank you to the 40 attendees who joined us this week for our Tax Planning Breakfast. After hearing AMD research updates from Deborah Ferrington, PhD, and year-end tax planning insights from Erik S. Hendrickson, ChFC®, of Northern Trust, guests enjoyed a guided tour of the Doheny Eye Institute. We’re grateful for such an engaged group to start the morning with.

11/14/2025

Join us for a Year-End Tax Planning Seminar at Doheny Eye Institute with Northern Trust. Learn the latest in AMD research and get practical tax strategies for year-end.

Tuesday, Nov 18, 9:00–11:00 AM
Breakfast included • Tours after the program

Speakers:
• Deborah A. Ferrington, PhD, Chief Scientific Officer, Doheny Eye Institute
• Erik S. Hendrickson, ChFC®, SVP, Managing Wealth Advisor, Northern Trust

RSVP: Sharon Takeyama — rsvp@doheny.org

11/11/2025

👁️ At today’s Work in Progress meeting, Yuhua Zhang, PhD presented his groundbreaking research on Higher-order Retinal Hemodynamics. Using advanced imaging, he tracks how individual red blood cells move with each heartbeat to better understand vessel health, stiffness, and stress.

Dr. Zhang’s work is advancing the growing field of oculomics, where detailed eye measurements reveal vital information about overall health and disease risk through a quick and noninvasive scan.

Doheny’s Work in Progress meetings give researchers the opportunity to share their research updates. Colleagues are invited to comment and ask questions which may spark new ideas, foster collaboration, and keep innovation moving forward.

11/07/2025

An evening to remember! 💫
Doheny donors gathered at the Valley Hunt Club for a special night of gratitude, vision, and music.
With words from CEO Marissa Goldberg and CSO Deborah A. Ferrington, PhD, and an extraordinary cello and piano performance by Joo Lee and Vanessa Fadial, the night was truly a treat.

Thank you to our generous supporters who make Doheny’s sight-saving work possible! 💜

11/06/2025

🚨 New Publication Alert!
We’re proud to share that new research co-authored by Doheny investigators Dr. Srinivas R. Sadda, Dr. Ram Kannan, and Dr. Sreekumar Parameswaran has been published in Aging Cell, a high-impact journal in aging and cell biology.

The study identifies how deficiency of the 2-oxoglutarate carrier (Slc25a11) can trigger harmful changes in retinal pigment epithelial (RPE) cells—accelerating subretinal fibrosis, a major cause of vision loss in neovascular age-related macular degeneration (AMD).

Understanding these molecular pathways is key to developing future therapies that could slow—or prevent—vision-threatening scarring.

🔬 This work sheds light on why some patients continue to lose vision despite current treatments—and where new treatments may emerge.

Congratulations to our Doheny researchers and collaborators!

11/03/2025

👁️✨ Incredible progress is happening in vision research!

A new article in Ophthalmology Times features Doheny Eye Institute’s Dr. Deborah Ferrington, who shares how advanced imaging, stem-cell technology, and AI are transforming how we understand and treat eye disease.

We’re proud to be at the forefront of these discoveries here at Doheny.

Read the article:
https://www.ophthalmologytimes.com/view/transformative-advances-in-vision-research-it-s-the-science

Deborah A. Ferrington, PhD, highlights how breakthroughs in imaging, AI, and stem cell research are reshaping ophthalmology.